RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today announced that management is preparing for a filing with the FDA for the Company’s First Warning System™, a capable process designed to assist in the early detection of breast cancer.
